|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development |
| 1. |
ARIAD Pharmaceuticals, Inc.
|
|
|
Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
|
| 2. |
Transmolecular, Inc.
|
|
|
Developing treatments in oncology. Includes overview of disease targets, technology, clinical trials, partnering opportunities and contacts for careers in Cambridge, Massachusetts.
|
| 3. |
Exelixis, Inc.
|
|
|
Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
|
| 4. |
ImmunoGen, Inc.
|
|
|
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
|
| 5. |
OSI Pharmaceuticals Inc.
|
|
|
Researches and develops diagnostics and anticancer therapy in humans and other diseases associated with control of cell growth. Laboratories in Oxford, Boulder and Farmingdale, headquartered in Melville, New York. (Nasdaq: OSIP)
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
